The claims this storefront makes
Liberty Peptides, operating as Liberty Products Group from a Wilmington, Delaware address, sells 72 listings in vials, capsules and blends, including a GLP-class product, at mid-market prices. The storefront’s banner says “99%+ Purity Guaranteed,” though another section softens that to “~99% Purity.” It describes its products as third-party tested and backs that with a public certificate library. It says its products are “Manufactured in the United States.” It states that it is not a 503A or 503B pharmacy, and it promises same-day shipping for orders placed before noon Eastern on business days. No GMP, ISO or facility certification is claimed. The one thing a buyer should know is that the supplier’s own site and the independent record describe two different companies.
We opened the certificate library and read its index fields, looked for a laboratory name on the site and in the index, read the about page and the shop, checked both the .com and the older .us domain, fetched the Trustpilot profile, read Finnrick’s vendor page and its June 2026 intelligence report, and searched FDA correspondence for the brand and the LLC.
What held up when we checked
The certificate library is real and more detailed than most. Seventy-one entries are viewable without a login, and each carries a sample name, a date tested, a purity figure, a net content figure and an endotoxin field. Very few suppliers publish endotoxin results at the index level, where a buyer can scan them without opening each document, and we noted that in the company’s favor. Mass spectrometry and endotoxin testing are both recorded as present in the program.
The company publishes an email address, info@libertypeptides.com, and a street address, Liberty Products Group, 300 Delaware Ave. Suite 210, Wilmington, DE 19801. It states that it is not a pharmacy, and it runs a 21-and-over age gate with a research-use disclaimer. Shipping is free over $200 with same-day dispatch before noon Eastern. The catalog of 72 listings spans vials, capsules and blends. The blends include a BPC-157 and TB-500 pairing and an Ipamorelin and CJC-1295 no DAC blend at 5 mg each, and the single items run to Tesamorelin, MOTS-c, GHK-Cu and SS-31 in 30 mg or 50 mg sizes, alongside one GLP-class product. Prices are mid-market: BPC-157 at 10 mg starts at $54 and the 10 mg and 20 mg range runs to $95, Sermorelin at 5 mg is $36, AOD-9604 at 5 mg is $50, LL-37 at 5 mg is $59 and P21 at 5 mg is $99.
What did not, and what we could not verify
The third-party testing claim is undermined by the one thing the library leaves out. No laboratory is named anywhere on the site or in the certificate index. Finnrick, an independent testing aggregator, reports that the certificates route through a laboratory called Horizon Analytical and that no ISO 17025 accreditation is claimed for it. A seventy-one-entry library with no signature is a seventy-one-entry claim.
The purity figure shifts. The banner says 99%+; another section says roughly 99 percent; and the independent record, covered below, says something else again. The “Manufactured in the United States” claim is also in question: Finnrick reports it could identify no domestic manufacturing facility, and notes that the about page also cites “renowned research chemical manufacturers globally,” which is hard to square with a domestic-manufacturing statement.
The older domain tells its own story. The Trustpilot profile for libertypeptides.us states that the website has closed and shows no TrustScore, with 11 reviews in the last 12 months. The .us domain is now an age gate that forwards to the .com. Payment methods are not stated anywhere, and the refund terms are linked but not displayed, so we could not read them.
The independent record is where this report turns. Finnrick’s testing shows 7 of 19 samples passing. BPC-157 scored 44 percent over four tests in Finnrick’s file, and CJC-1295 scored 22 percent. Finnrick’s intelligence report dated June 13, 2026 adds the following, which we attribute to Finnrick and have not independently confirmed: Liberty Products Group LLC was formed in Delaware on October 25, 2024 and is listed as not in good standing; the storefront domain launched on December 5, 2023, before the LLC existed; a hidden source-code link on libertypeptides.us points to BioBoost Labs LLC at a Texas residential address; and the .us age gate also links to bioboostlabsllc.com. The supplier may have answers to each of those points. It has not given them on its site.
We could not verify whether HPLC is the purity method, whether sterility testing is performed, whether international orders are accepted or by which carriers, or the founding year. There is no 5 mg BPC-157 price because none is sold. No FDA warning letter naming Liberty Peptides or Liberty Products Group appears in our record.
Our read
Liberty Peptides looks, on its own site, like a mid-tier supplier with an unusually full certificate index and a published Delaware address. The independent record tells a different story: fewer than four in ten retests pass, the laboratory behind the certificates is unnamed on the site and unaccredited by Finnrick’s account, the entity’s standing is in question, and the storefront predates the company that supposedly runs it. None of that is proven by us, and we say so. But a supplier facing published questions of that kind has every reason to answer them, and this one has not.
Until the pass rate improves and the entity questions are addressed publicly, the certificate library should be read as the supplier’s claim, not as corroboration of it. A buyer who orders anyway should treat the retest data as the better guide to what arrives, and should not expect the Delaware address to lead to a facility.
